FDA Cracks Down on Companies Selling Unapproved CBD Products By Diana Ernst, RPh Publish Date March 23, 2021
Valerian Quality, Storage Issues May Affect Sleep Outcomes By Cassandra Pardini, PharmD Publish Date November 6, 2020
Supplements With Undeclared Active Ingredients Pose Substantial Health Risk By Cassandra Pardini, PharmD Publish Date June 25, 2020
Warning Letters Issued to Several Companies Selling Unapproved “Homeopathic” Injectables By Diana Ernst, RPh Publish Date June 18, 2020
FDA, FTC Crack Down on Fraudulent COVID-19 “Treatments” By Diana Ernst, RPh Publish Date March 10, 2020
Adding Curcumin to Mesalamine May Benefit Patients With Ulcerative Colitis By Cassandra Pardini, PharmD Publish Date January 22, 2020
Lavender-Based Interventions Evaluated for Anxiety Treatment By Cassandra Pardini, PharmD Publish Date November 4, 2019
Consider CBD-Drug Interaction Potential: An Expert Interview By Batya Swift Yasgur, MA, LSW Publish Date October 25, 2019
“Liver Cleanse” Linked to INR Increase in Warfarin-Treated Patient By Diana Ernst, RPh Publish Date October 24, 2019
Acute Pancreatitis Linked to Black Elderberry Extract By Diana Ernst, RPh Publish Date October 17, 2019
Review Investigates Effects of Intermittent Fasting By Diana Ernst, RPh Publish Date October 16, 2019